On April 26, 2024, Aclarion, Inc., a company listed on the Nasdaq Stock Market under the symbol ACON, successfully raised $304,500 in new capital funding. This was achieved through the sale of 1.05 million shares of common stock, utilizing the company's existing equity line facility. As a result of this transaction, the total number of Aclarion's outstanding common shares has increased to 8,203,500. The company also secured a limited waiver under the Placement Agent Agreement and Securities Purchase Agreements from its February 27, 2024 public offering, which allowed the equity line transactions to proceed. The report was officially signed by John Lorbiecki, Chief Financial Officer of Aclarion, Inc., on April 29, 2024.

On April 26, 2024, Aclarion, Inc., a company listed on the Nasdaq Stock Market under the symbol ACON, successfully raised $304,500 in new capital funding. This was achieved through the sale of 1.05 million shares of common stock, utilizing the company's existing equity line facility. As a result of this transaction, the total number of Aclarion's outstanding common shares has increased to 8,203,500. The company also secured a limited waiver under the Placement Agent Agreement and Securities Purchase Agreements from its February 27, 2024 public offering, which allowed the equity line transactions to proceed. The report was officially signed by John Lorbiecki, Chief Financial Officer of Aclarion, Inc., on April 29, 2024.